Medicines / Emcure Pharmaceuticals / Lavir
LavirLamivudine
Lavir is marketed by Emcure Pharmaceuticals. 2 packs on NPPA's price list for July 2026, containing Lamivudine.
- Packs listed
- 2
- Lowest MRP
- ₹85.00
- Per unit
- ₹0.85 to ₹10.66
- Price-controlled packs
- 1 of 2
- Dosage forms
- 2
Packs and prices
- ₹85.00Lavir 150 mg Solution 100 mlLamivudine Oral Solution 150 mg · ₹0.85 per ml
- ₹639.74Lavir 150 mg Tablet 60Lamivudine Tablet 150 mg · ₹10.66 per tablet · price-controlled, ceiling ₹11.12 per tablet
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Lamivudine Tablet 150 mg
- ₹9.27/tabletHeptavir · 10 tabletHetero Healthcare · MRP ₹92.65 · price-controlled, ceiling ₹11.12 per tablet
- ₹11.60/tabletLamivir · 10 tabletCipla · MRP ₹116.02 · price-controlled, ceiling ₹11.12 per tablet
2 other brands of this composition on the price list; the 2 lowest per tablet are shown. All Lamivudine packs
The company
Emcure Pharmaceuticals has 1,373 packs on the price list, and CDSCO has named it as the manufacturer of 4 failed batches since Mar 2019. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.